Clinical Trials Using Beta-lapachone Prodrug ARQ 761
Clinical trials are research studies that involve people. The clinical trials on this list are studying Beta-lapachone Prodrug ARQ 761. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Beta-lapachone Prodrug ARQ 761 and Combination Chemotherapy in Treating Patients with Pancreatic Cancer That Is Metastatic, Recurrent, or Cannot Be Removed by Surgery
This phase I / Ib trial studies the side effects and best dose of beta-lapachone prodrug ARQ 761 when given together with gemcitabine hydrochloride and nab-paclitaxel in treating patients with pancreatic cancer that has spread to other places in the body, cannot be removed by surgery, or has come back. Drugs used in chemotherapy, such as beta-lapachone prodrug ARQ 761, gemcitabine hydrochloride, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Location: 2 locations